Create issue ticket

9,972 Possible Causes for 34, Droncit, MG, Oral, Tablet

  • Rizatriptan

    37 38 1 35 29 30 1 36 39 38 2 37 39 41 1 38 41 42 1 39 42 43 1 40 42 46 1 41 46 45 2 42 45 44 1 43 43 44 2 44 31 32 1 45 32 33 1 46 33 34 1 47 34 35 1 48 34 36 1 BRACKET[genome.jp] 50 mg as well as rizatriptan 5 mg compared with sumatriptan 25 mg in the acute treatment of migraine.[ncbi.nlm.nih.gov] Rizatriptan benzoate tablets are available as a traditional tablet and as an orally disintegrating tablet.[dailymed.nlm.nih.gov] BACKGROUND: In the clinical trial setting, oral rizatriptan 10 mg has greater efficacy than other oral triptans in freedom from migraine headache pain 2 h after dosing.[ncbi.nlm.nih.gov] Clin Neuropharmacol. 2011 Nov-Dec;34(6):206-9. doi: 10.1097/WNF.0b013e31823429cd.[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Zolmitriptan

    RESULTS: Initial examination revealed unaided visual acuities of 20/100 in the right eye and 20/125 in the left, with IOP measuring 34 mm Hg bilaterally.[ncbi.nlm.nih.gov] The early efficacy (30 minutes) of the 5 mg dose of the zolmitriptan ODT formulation was evaluated.[ncbi.nlm.nih.gov] Zolmitriptan ODT is a convenient and beneficial alternative to conventional tablets and is preferred to sumatriptan conventional tablets by migraineurs.[ncbi.nlm.nih.gov] Of those patients stating a preference, 70% of patients preferred the orally disintegrating tablet to a conventional tablet.[ncbi.nlm.nih.gov] The second patient is a 34-year-old man with a past medical history significant only for life-long migraine headaches successfully treated for the past six years with zolmitriptan[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Propantheline

    Price from Propantheline bromide manufacturers Propantheline bromide US 1.00 / kg 2018-12-24 CAS:50-34-0 Min.[chemicalbook.com] Pregnancy (category C), lactation; narrow angle glaucoma; tachycardia, MI; paralytic ileus, GI obstructive disease; myasthenia gravis.[robholland.com] The only significant differences in AUC were seen when comparing tablets alone versus tablets with cholestyramine (P less than .0005) and tablets with propantheline (P less[ncbi.nlm.nih.gov] Abstract The present study shows that a single oral recommended dose of propantheline bromide normally doubles the mean gastric half-emptying time in man.[ncbi.nlm.nih.gov] Oral propantheline, at dose levels currently recommended for therapeutic use, was without significant effect on ethanol tolerance, whereas the tolerance was reduced by oral[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Urinary Tract Infection

    […] from patients with community-acquired (CA)-UTIs (n   29) were tested for their adhesion to, invasion and translocation through Caco-2 cells, in addition to the presence of 34[ncbi.nlm.nih.gov] gravis inherent resistance in Gram-positive bacteria, anaerobes, Proteeae, S erratia spp., Providencia spp. salvage therapy for infection with resistant ESBL-producing organisms[doi.org] A final study reported fewer UTIs during the period with cranberry extract tablets vs placebo.[ncbi.nlm.nih.gov] MAIN RESULTS: Hospital days on antibiotics as well as length of stay were less in the group treated with any oral antibiotics (intravenous/oral, median 5 [IQR 3-7] days vs[ncbi.nlm.nih.gov] The outcomes were assessed after catheter removed.After catheter removal, the occurrence of an UTI did not differ significantly between the 2 groups (P   .34).[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Almotriptan

    The most frequent trigger during the study was stress (37% of migraine attacks), with poor sleep (34%), fatigue (32%) and menses (19%) also being widely reported.[ncbi.nlm.nih.gov] Patients were instructed to take a single 12.5-mg dose of almotriptan at the onset of a migraine attack.[ncbi.nlm.nih.gov] INDICATION AXERT tablets are indicated for the acute treatment of migraine with or without aura in adults.[web.archive.org] OBJECTIVE: To summarize safety and tolerability data on orally administered almotriptan from premarketing clinical trials.[ncbi.nlm.nih.gov] The main reason for preference for one or the other triptan was efficacy: 43% of patients preferring almotriptan gave faster headache relief as the reason and 34% cited faster[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Sumatriptan

    […] evident as early as 15 minutes, reached statistical significance at 30 minutes post-dose (42% vs 27%, P .03), and were sustained at 24 hours (44% vs 24%, P .002) and 48 hours (34%[ncbi.nlm.nih.gov] […] or 6 mg).[ncbi.nlm.nih.gov] Australian Register Numbers: 100mg tablets: AUST R 187215 50mg tablets: AUST R 187214[nps.org.au] CONCLUSIONS: Patients without cardiac risk factors may experience myocardial infarction following an oral dose of sumatriptan.[ncbi.nlm.nih.gov] Neurology . 1984; 34:1292-8. 189. Rapoport AM, Visser WH, Cutler NR et al.[drugs.com]

    Missing: Droncit
  • Ondansetron

    Finally group 0 encompassed 35 patients administered ondansetron 8 mg i.v. dissolved in 10 ml 0.9% NaCl whereas group P consisted of 34 patients receiving 0.9% NaCl 10 mg.[ncbi.nlm.nih.gov] mg.[fda.gov] , Orally Disintegrating Tablets and Oral Solution The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating[web.archive.org] RESULTS: PONV in the first 24 h occurred in 45 (34 to 60)% of patients who received prophylaxis and 54 (41 to 67)% in the placebo group (P   0.35).[ncbi.nlm.nih.gov] This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO Guide 34 guidelines.[caymanchem.com]

    Missing: Droncit
  • Cladribine

    RESULTS: Complete remission rate in the DAC arm was higher compared with the DA arm (67.5% v 56%; P .01) as a consequence of reduced incidence of resistant disease (21% v 34%[ncbi.nlm.nih.gov] There were five planned temsirolimus i.v. dose levels: 15 mg day 1; 25 mg day 1; 25 mg days 1 and 15; 25 mg days 1, 8 and 15; and 25 mg days 1, 8, 15, and 22.[ncbi.nlm.nih.gov] In 2011, the development of cladribine tablets was stopped following negative feedback from the EMA and FDA.[ncbi.nlm.nih.gov] We report the results of a 96-week phase 3 trial of a short-course oral tablet therapy in patients with relapsing-remitting multiple sclerosis.[ncbi.nlm.nih.gov] […] cladribine-containing treatment, and only 10/42 (24%) responding patients needed further treatment after a median time to progression of 14 months (interquartile range, 8-34[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Eletriptan

    .0052); and on the FAIM-IMMF (50% vs 34%; n 215; P .017).[ncbi.nlm.nih.gov] -Eletriptan 80 mg has demonstrated significantly greater efficacy when compared to both sumatriptan 50 mg and 100 mg in two studies.[ncbi.nlm.nih.gov] The objective of this study was to compare patient preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.[ncbi.nlm.nih.gov] Healthy males received single oral doses of 10 to 120 mg.[ncbi.nlm.nih.gov] In the initial attack, significantly more eletriptan patients reported headache relief and complete pain relief at 2 h vs. placebo (40 mg 62% and 32%, 80 mg 65% and 34%, placebo[ncbi.nlm.nih.gov]

    Missing: Droncit
  • Naratriptan

    […] systemic vascular resistance (95% CI, 74-253 dyn/s/cc; p 0.003), pulmonary artery systolic pressure (95% CI, 2.0-6.9 mm Hg; p 0.003), pulmonary vascular resistance (95% CI, 3-34[ncbi.nlm.nih.gov] This randomized, double-masked, double-dummy, placebo-controlled study compared rizatriptan 10 mg to naratriptan (NARAMIG(TM), AMERGE(TM), both Glaxo Wellcome plc) 2.5 mg[ncbi.nlm.nih.gov] The median number of naratriptan tablets used per attack was 1.0 (mean 1.25); patients treated only a median 7% of attacks (mean 13%) with a 2nd naratriptan tablet for headache[ncbi.nlm.nih.gov] The second (attack 2) was a randomized, parallel group, double-blind, placebo-controlled trial of naratriptan (2.5 mg orally) in nonresponders to oral sumatriptan.[ncbi.nlm.nih.gov] Naratriptan 2.5 mg (34% preference) was superior to naproxen sodium 500 mg (25% preference).[ncbi.nlm.nih.gov]

    Missing: Droncit

Similar symptoms